Form 4: Exact Sciences Director Sells All Shares Post-Abbott Merger

Exact Sciences Director Shacey Petrovic disposed of all common stock holdings following the company's acquisition by Abbott Laboratories for $105.00 per share.

Summary

• Reporting Person Shacey Petrovic, a Director of Exact Sciences Corporation, disposed of all her beneficial ownership in the company's common stock.
• The transactions occurred on March 23, 2026, pursuant to a merger agreement dated November 19, 2025.
• Exact Sciences Corporation merged with Badger Merger Sub I, Inc., a wholly-owned subsidiary of Abbott Laboratories, with Exact Sciences surviving as a wholly-owned subsidiary of Abbott.
• Each share of Exact Sciences common stock was converted into the right to receive $105.00 in cash, without interest.
• Shares subject to vesting were fully vested, cancelled, and converted into the right to receive the $105.00 cash merger consideration, less applicable tax withholding.
• Petrovic disposed of 16,406 shares directly, then an additional 5,398 shares directly, and 7,095 shares indirectly held by a grantor retained annuity trust.
• Following these transactions, Petrovic holds 0 shares of Exact Sciences common stock.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a neutral event for the market, as it reports the expected completion of a previously announced merger, providing a clear cash exit for shareholders. The director's disposition of shares is a procedural outcome of the acquisition.

Positives

• Shareholders received a cash consideration of $105.00 per share for their Exact Sciences common stock, providing a clear exit and liquidity.
• The merger provided a defined return on investment for Exact Sciences shareholders.

Negatives

• Exact Sciences Corporation ceased to be an independent publicly traded entity, becoming a wholly-owned subsidiary of Abbott Laboratories.
• The reporting person, a director, no longer holds any beneficial ownership in the company.

Future Outlook

The filing indicates the completion of the merger, resulting in Exact Sciences becoming a wholly-owned subsidiary of Abbott Laboratories. There are no forward-looking statements regarding Exact Sciences' future as an independent entity.

Industry Context

StockSavvy.ai notes that this acquisition by Abbott Laboratories reflects a trend of consolidation within the diagnostics and medical technology sectors, where larger players seek to expand their portfolios and market reach through strategic mergers. The cash consideration suggests a premium valuation for Exact Sciences' assets and market position.

Comparison to Industry Standards

• StockSavvy.ai observes that the $105.00 per share cash consideration aligns with typical premiums seen in strategic acquisitions within the healthcare and diagnostics industry.
• Similar transactions, such as Roche's acquisition of GenMark Diagnostics or Danaher's acquisition of Cytiva, often involve significant cash components reflecting the target company's innovation and market share.
• While specific comparable deal multiples are not provided in this filing, the all-cash nature provides immediate liquidity and certainty for Exact Sciences shareholders, a common feature in mature industry consolidations.

Management Changes

Corporate Governance

Stakeholder Impact

• Shareholders: Received $105.00 cash per share, providing liquidity and a defined return on investment.
• Employees: Exact Sciences employees are now part of Abbott Laboratories, potentially impacting roles, benefits, and corporate culture.
• Customers: Exact Sciences' products and services will now be offered under the Abbott Laboratories umbrella, potentially leading to broader distribution or integration with Abbott's existing portfolio.

Next Steps

• Exact Sciences Corporation will operate as a direct, wholly-owned subsidiary of Abbott Laboratories.
• No further public trading of Exact Sciences common stock.

Key Dates

Keywords

Exact Sciences, EXAS, Abbott Laboratories, Merger, Acquisition, Form 4, Insider Transaction, Stock Sale, Cash Out, Corporate Action